公司概覽
業務類別 Medical Instruments & Supplies
業務概覽 Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
公司地址 250 Campus Drive, Marlborough, MA, USA, 01752
電話號碼 +1 508 263-2900
傳真號碼 --
公司網頁 https://www.hologic.com
員工數量 7070
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Ms. Jennifer Schneiders President, Diagnostics Solutions -- 16/01/2025
Mr. Brandon Schnittker Division President, GYN Surgical Solutions -- 16/01/2025
Mr. Mark Horvath Division President, Breast and Skeletal Health Solutions -- 16/01/2025
Mr. Stephen P. Macmillan Chairman of the Board, Chief Executive Officer and President 美元 1.21M 18/11/2025
Ms. Karleen M. Oberton Chief Financial Officer 美元 694.23K 18/11/2025
Ms. Diana De Walt Senior Vice President, Human Resources -- 16/01/2025
Mr. Benjamin J. Cohn Vice President, Corporate Controller and Principal Accounting Officer -- 18/11/2025
Mr. Jan Verstreken Group President, International 美元 693.40K 16/01/2025
Mr. Essex D. Mitchell Chief Operating Officer 美元 592.69K 16/01/2025
 
董事會成員
董事會 職務 更新日期
Ms. Stacey D. Stewart Independent Director 18/11/2025
Mr. Charles J. Dockendorff Independent Director 18/11/2025
Mr. Stephen P. Macmillan Chairman of the Board, Chief Executive Officer and President 18/11/2025
Ms. Amy A. Wendell Lead Independent Director 18/11/2025
Dr. Ludwig N. Hantson, PhD Independent Director 18/11/2025
Ms. Christiana Stamoulis, M.B.A. Independent Director 18/11/2025
Ms. Nanaz Mohtashami Independent Director 18/11/2025
Mr. Wayde D. McMillan Director 18/11/2025
Dr. Martin D. Madaus,PhD Director 18/11/2025
 
所屬ETF (更新日期: 07/03/2026 03:19)
代號 名稱 佔比% 持有日期
PHDGInvesco S&P 500® Downside Hedged ETF0.0001%27/02/2026
CDEICalvert US Large-Cp Div, Eq AndIncETF0.0001%27/02/2026
XRMIGlobal X S&P 500® Risk Managed Inc ETF0.0001%27/02/2026
JUSAJPMorgan U.S. Research Enh Lg Cp ETF0.0001%27/02/2026
XBFRInnovator Equity Managed 10 Buffer ETF0.0001%27/02/2026
FCFYFirst Trust S&P 500 Div Fr CA Flw ETF0.0001%26/02/2026
QRFTQRAFT AI-Enhanced US Large Cap ETF0.00004%27/02/2026
CHRIGlobal X S&P 500 Christian Values ETF0.00001%27/02/2026
SPUTInnovator Eq Prm Inc -Daily PutWrite ETF0.00001%23/02/2026
SPXDXtrackers S&P 500 Divers Sect Weight ETF0.00001%26/02/2026
GXLCGlobal X U.S. 500 ETF0.00001%27/02/2026
RVRBReverb ETF0.00001%27/02/2026
XCLRGlobal X S&P 500® Collar 95-110 ETF0.00001%27/02/2026
XTRGlobal X S&P 500® Tail Risk ETF0.00001%27/02/2026
EGLEGlobal X S&P 500 U.S. Rev Ldrs ETF0.000004%27/02/2026
FBProshares S&P 500 Dynamic Buffer ETF0.000003%30/11/2025
ABFLAbacus FCF Leaders ETF<0.000001%27/02/2026
ABOTAbacus FCF Innovation Leaders ETF<0.000001%27/02/2026
AFLGFirst Trust Active Factor Large Cap ETF<0.000001%07/12/2025
AIEQAI Powered Equity ETF<0.000001%28/07/2023
  1    2    3    4    5    6    7    8   9    10    11    12    13    14  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.